Key result
A premature infant with congenital Chagas disease was successfully treated with a 60-day course of benznidazole, achieving a negative PCR test 21 days after treatment initiation.
Population
1 male infant born at 30 weeks' gestation via Cesarean section, birth weight 1785g, with congenital Chagas…
Design
Case_report
Follow-up
7 months
Authors
Loading...
May prompt Chagas screening in unexplained pediatric cardiomyopathy; leaves open generalizability and need for prospective data.
Case Report (n=1)
This case demonstrates the successful treatment of congenital Chagas disease with benznidazole in a premature infant, highlighting the importance of screening at-risk pregnant women.
Alarcón et al. (2016) conducted a case report in Congenital Chagas Disease (n=1). Benznidazole was evaluated on Clearance of Trypanosoma cruzi infection (negative PCR). A premature infant with congenital Chagas disease was successfully treated with a 60-day course of benznidazole, achieving a negative PCR test 21 days after treatment initiation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: